LisaAnnBeckMD
Dermatology • Rochester, NYProfessor, Dermatology, Medicine and Pathology, University of Rochester School of Medicine & Dentistry
Dr. Beck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Crittenden Blvd
Rochester, NY 14642Phone+1 585-275-7546Fax+1 585-461-3509
Education & Training
Johns Hopkins UniversityPost-Doctoral Fellowship, Allergy and Immunology, 1992 - 1994
Duke University HospitalResidency, Dermatology, 1987 - 1990
University of RochesterResidency, Internal Medicine, 1985 - 1987
Stony Brook University Health Sciences Center School of MedicineClass of 1985
Certifications & Licensure
NY State Medical License 2006 - 2025
MD State Medical License 1990 - 2006
NC State Medical License 1987 - 1992- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis Start of enrollment: 2008 Aug 01
- Registry for the Atopic Dermatitis Research Network Start of enrollment: 2011 Aug 01
- Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients Start of enrollment: 2013 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials.Daniel G Rayner, Ming Liu, Alexandro W L Chu, Xiajing Chu, Gordon H Guyatt
The Journal of Allergy and Clinical Immunology. 2024-10-01 - 1 citationsTopical corticosteroids for hives and itch (urticaria): Systematic review and Bayesian meta-analysis of randomized trials.Alexandro W L Chu, Daniel G Rayner, Xiajing Chu, Lina Chen, Audrey Y H Dong
Annals of Allergy, Asthma & Immunology. 2024-10-01 - CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity.H Mark Kenney, Takeshi Yoshida, Evgeny Berdyshev, Agustin Calatroni, Steven R Gill
The Journal of Allergy and Clinical Immunology. 2024-09-27
Journal Articles
- Image Gallery: Hairy‐Cell Leukaemia Presenting with Sweet SyndromeG Scott, L A Beck, The British Journal of Dermatology
Press Mentions
Every-Other-Week Dose of Dupilumab Safe, Effective over Long TermMay 12th, 2022- DermTech Announces New Scientific Advisory Board MembersFebruary 8th, 2021
Research Finds Needleless Flu Vaccine Patch to Be EffectiveSeptember 19th, 2019- Join now to see all
Grant Support
- Mechanisms Of Chemokine-Induced Inflammation In HumansNational Institute Of Allergy And Infectious Diseases2001–2005
- Steroid Mechanisms In Cutaneous Allergic InflammationNational Institute Of Allergy And Infectious Diseases1994–1998
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
